XML 88 R47.htm IDEA: XBRL DOCUMENT v3.20.1
ACQUISITION, LICENSING AGREEMENTS AND ASSETS HELD FOR SALE - Narrative (Details)
$ in Millions
3 Months Ended 10 Months Ended 12 Months Ended
Mar. 06, 2019
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
product
Dec. 31, 2019
USD ($)
product
Dec. 31, 2018
USD ($)
Business Acquisition [Line Items]              
Advisory, legal, valuation, accounting and other similar services, included in other (income) expense   $ 23   $ (3)      
Assets reclassified, held and used   31,865     $ 33,863 $ 33,863  
Disposal Group, Held-for-sale, Not Discontinued Operations | Certain Products For Disposal, September 2019              
Business Acquisition [Line Items]              
Revenue associated with products for disposal           $ 14 $ 19
Impairment of long-lived assets classified as held for sale     $ 8        
Disposal Group, Held-for-sale, Not Discontinued Operations | Certain Products For Disposal, September 2019 | Restatement Adjustment              
Business Acquisition [Line Items]              
Assets reclassified, held for sale   39          
Assets reclassified, held and used   $ 39          
Disposal Group, Held-for-sale, Not Discontinued Operations | Certain Products For Disposal, September 2019 | Diversified Products              
Business Acquisition [Line Items]              
Number of products for disposal | product         1 1  
Synergy Pharmaceuticals Inc.              
Business Acquisition [Line Items]              
Cash payments to acquire certain assets and assumed liabilities $ 180            
Revenue of acquiree since acquisition date         $ 55    
Operating results of acquiree since acquisition         $ 0    
Pro forma revenue       0   $ 0  
Pro forma operating results       0   $ 0  
Advisory, legal, valuation, accounting and other similar services, included in other (income) expense       $ 8